Global Human Recombinant Insulin Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Recombinant Insulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Recombinant Insulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Recombinant Insulin by Country/Region, 2017, 2022 & 2028

2.2 Human Recombinant Insulin Segment by Type

2.2.1 Rapid-Acting Human Insulin

2.2.2 Regular (Short Acting) Insulin

2.2.3 NPH (Intermediate Acting) Insulin

2.2.4 Long-Acting Human Insulin

2.2.5 Premixed Human Insulins Insulin

2.3 Human Recombinant Insulin Sales by Type

2.3.1 Global Human Recombinant Insulin Sales Market Share by Type (2017-2022)

2.3.2 Global Human Recombinant Insulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Recombinant Insulin Sale Price by Type (2017-2022)

2.4 Human Recombinant Insulin Segment by Application

2.4.1 Hospital

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacies

2.4.4 Other

2.5 Human Recombinant Insulin Sales by Application

2.5.1 Global Human Recombinant Insulin Sale Market Share by Application (2017-2022)

2.5.2 Global Human Recombinant Insulin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Recombinant Insulin Sale Price by Application (2017-2022)

3 Global Human Recombinant Insulin by Company

3.1 Global Human Recombinant Insulin Breakdown Data by Company

3.1.1 Global Human Recombinant Insulin Annual Sales by Company (2020-2022)

3.1.2 Global Human Recombinant Insulin Sales Market Share by Company (2020-2022)

3.2 Global Human Recombinant Insulin Annual Revenue by Company (2020-2022)

3.2.1 Global Human Recombinant Insulin Revenue by Company (2020-2022)

3.2.2 Global Human Recombinant Insulin Revenue Market Share by Company (2020-2022)

3.3 Global Human Recombinant Insulin Sale Price by Company

3.4 Key Manufacturers Human Recombinant Insulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Recombinant Insulin Product Location Distribution

3.4.2 Players Human Recombinant Insulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Recombinant Insulin by Geographic Region

4.1 World Historic Human Recombinant Insulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Recombinant Insulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Recombinant Insulin Annual Revenue by Geographic Region

4.2 World Historic Human Recombinant Insulin Market Size by Country/Region (2017-2022)

4.2.1 Global Human Recombinant Insulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Recombinant Insulin Annual Revenue by Country/Region

4.3 Americas Human Recombinant Insulin Sales Growth

4.4 APAC Human Recombinant Insulin Sales Growth

4.5 Europe Human Recombinant Insulin Sales Growth

4.6 Middle East & Africa Human Recombinant Insulin Sales Growth

5 Americas

5.1 Americas Human Recombinant Insulin Sales by Country

5.1.1 Americas Human Recombinant Insulin Sales by Country (2017-2022)

5.1.2 Americas Human Recombinant Insulin Revenue by Country (2017-2022)

5.2 Americas Human Recombinant Insulin Sales by Type

5.3 Americas Human Recombinant Insulin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Recombinant Insulin Sales by Region

6.1.1 APAC Human Recombinant Insulin Sales by Region (2017-2022)

6.1.2 APAC Human Recombinant Insulin Revenue by Region (2017-2022)

6.2 APAC Human Recombinant Insulin Sales by Type

6.3 APAC Human Recombinant Insulin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Recombinant Insulin by Country

7.1.1 Europe Human Recombinant Insulin Sales by Country (2017-2022)

7.1.2 Europe Human Recombinant Insulin Revenue by Country (2017-2022)

7.2 Europe Human Recombinant Insulin Sales by Type

7.3 Europe Human Recombinant Insulin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Recombinant Insulin by Country

8.1.1 Middle East & Africa Human Recombinant Insulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Recombinant Insulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Recombinant Insulin Sales by Type

8.3 Middle East & Africa Human Recombinant Insulin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Recombinant Insulin

10.3 Manufacturing Process Analysis of Human Recombinant Insulin

10.4 Industry Chain Structure of Human Recombinant Insulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Recombinant Insulin Distributors

11.3 Human Recombinant Insulin Customer

12 World Forecast Review for Human Recombinant Insulin by Geographic Region

12.1 Global Human Recombinant Insulin Market Size Forecast by Region

12.1.1 Global Human Recombinant Insulin Forecast by Region (2023-2028)

12.1.2 Global Human Recombinant Insulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Recombinant Insulin Forecast by Type

12.7 Global Human Recombinant Insulin Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Human Recombinant Insulin Product Offered

13.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Eli Lilly and Company

13.2.1 Eli Lilly and Company Company Information

13.2.2 Eli Lilly and Company Human Recombinant Insulin Product Offered

13.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly and Company Main Business Overview

13.2.5 Eli Lilly and Company Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Human Recombinant Insulin Product Offered

13.3.3 Sanofi Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Julphar Gulf Pharmaceutical Industries

13.4.1 Julphar Gulf Pharmaceutical Industries Company Information

13.4.2 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product Offered

13.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Julphar Gulf Pharmaceutical Industries Main Business Overview

13.4.5 Julphar Gulf Pharmaceutical Industries Latest Developments

13.5 Bioton

13.5.1 Bioton Company Information

13.5.2 Bioton Human Recombinant Insulin Product Offered

13.5.3 Bioton Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bioton Main Business Overview

13.5.5 Bioton Latest Developments

13.6 Gan & Lee Pharmaceuticals

13.6.1 Gan & Lee Pharmaceuticals Company Information

13.6.2 Gan & Lee Pharmaceuticals Human Recombinant Insulin Product Offered

13.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Gan & Lee Pharmaceuticals Main Business Overview

13.6.5 Gan & Lee Pharmaceuticals Latest Developments

13.7 Zhuhai United Laboratories

13.7.1 Zhuhai United Laboratories Company Information

13.7.2 Zhuhai United Laboratories Human Recombinant Insulin Product Offered

13.7.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Zhuhai United Laboratories Main Business Overview

13.7.5 Zhuhai United Laboratories Latest Developments

13.8 Biocon

13.8.1 Biocon Company Information

13.8.2 Biocon Human Recombinant Insulin Product Offered

13.8.3 Biocon Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biocon Main Business Overview

13.8.5 Biocon Latest Developments

13.9 Wanbang Biopharmaceuticals

13.9.1 Wanbang Biopharmaceuticals Company Information

13.9.2 Wanbang Biopharmaceuticals Human Recombinant Insulin Product Offered

13.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Wanbang Biopharmaceuticals Main Business Overview

13.9.5 Wanbang Biopharmaceuticals Latest Developments

13.10 Dongbao Enterprise Group

13.10.1 Dongbao Enterprise Group Company Information

13.10.2 Dongbao Enterprise Group Human Recombinant Insulin Product Offered

13.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Dongbao Enterprise Group Main Business Overview

13.10.5 Dongbao Enterprise Group Latest Developments

13.11 PeproTech

13.11.1 PeproTech Company Information

13.11.2 PeproTech Human Recombinant Insulin Product Offered

13.11.3 PeproTech Human Recombinant Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 PeproTech Main Business Overview

13.11.5 PeproTech Latest Developments

14 Research Findings and Conclusion

Table 1. Human Recombinant Insulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Recombinant Insulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rapid-Acting Human Insulin

Table 4. Major Players of Regular (Short Acting) Insulin

Table 5. Major Players of NPH (Intermediate Acting) Insulin

Table 6. Major Players of Long-Acting Human Insulin

Table 7. Major Players of Premixed Human Insulins Insulin

Table 8. Global Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)

Table 9. Global Human Recombinant Insulin Sales Market Share by Type (2017-2022)

Table 10. Global Human Recombinant Insulin Revenue by Type (2017-2022) & ($ million)

Table 11. Global Human Recombinant Insulin Revenue Market Share by Type (2017-2022)

Table 12. Global Human Recombinant Insulin Sale Price by Type (2017-2022) & (USD/Litre)

Table 13. Global Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)

Table 14. Global Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Table 15. Global Human Recombinant Insulin Revenue by Application (2017-2022)

Table 16. Global Human Recombinant Insulin Revenue Market Share by Application (2017-2022)

Table 17. Global Human Recombinant Insulin Sale Price by Application (2017-2022) & (USD/Litre)

Table 18. Global Human Recombinant Insulin Sales by Company (2020-2022) & (K Litre)

Table 19. Global Human Recombinant Insulin Sales Market Share by Company (2020-2022)

Table 20. Global Human Recombinant Insulin Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Human Recombinant Insulin Revenue Market Share by Company (2020-2022)

Table 22. Global Human Recombinant Insulin Sale Price by Company (2020-2022) & (USD/Litre)

Table 23. Key Manufacturers Human Recombinant Insulin Producing Area Distribution and Sales Area

Table 24. Players Human Recombinant Insulin Products Offered

Table 25. Human Recombinant Insulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Human Recombinant Insulin Sales by Geographic Region (2017-2022) & (K Litre)

Table 29. Global Human Recombinant Insulin Sales Market Share Geographic Region (2017-2022)

Table 30. Global Human Recombinant Insulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Human Recombinant Insulin Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Human Recombinant Insulin Sales by Country/Region (2017-2022) & (K Litre)

Table 33. Global Human Recombinant Insulin Sales Market Share by Country/Region (2017-2022)

Table 34. Global Human Recombinant Insulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Human Recombinant Insulin Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)

Table 37. Americas Human Recombinant Insulin Sales Market Share by Country (2017-2022)

Table 38. Americas Human Recombinant Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Human Recombinant Insulin Revenue Market Share by Country (2017-2022)

Table 40. Americas Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)

Table 41. Americas Human Recombinant Insulin Sales Market Share by Type (2017-2022)

Table 42. Americas Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)

Table 43. Americas Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Table 44. APAC Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)

Table 45. APAC Human Recombinant Insulin Sales Market Share by Region (2017-2022)

Table 46. APAC Human Recombinant Insulin Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Human Recombinant Insulin Revenue Market Share by Region (2017-2022)

Table 48. APAC Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)

Table 49. APAC Human Recombinant Insulin Sales Market Share by Type (2017-2022)

Table 50. APAC Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)

Table 51. APAC Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Table 52. Europe Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)

Table 53. Europe Human Recombinant Insulin Sales Market Share by Country (2017-2022)

Table 54. Europe Human Recombinant Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Human Recombinant Insulin Revenue Market Share by Country (2017-2022)

Table 56. Europe Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)

Table 57. Europe Human Recombinant Insulin Sales Market Share by Type (2017-2022)

Table 58. Europe Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)

Table 59. Europe Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)

Table 61. Middle East & Africa Human Recombinant Insulin Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Human Recombinant Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Human Recombinant Insulin Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)

Table 65. Middle East & Africa Human Recombinant Insulin Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)

Table 67. Middle East & Africa Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Human Recombinant Insulin

Table 69. Key Market Challenges & Risks of Human Recombinant Insulin

Table 70. Key Industry Trends of Human Recombinant Insulin

Table 71. Human Recombinant Insulin Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Human Recombinant Insulin Distributors List

Table 74. Human Recombinant Insulin Customer List

Table 75. Global Human Recombinant Insulin Sales Forecast by Region (2023-2028) & (K Litre)

Table 76. Global Human Recombinant Insulin Sales Market Forecast by Region

Table 77. Global Human Recombinant Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Human Recombinant Insulin Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Human Recombinant Insulin Sales Forecast by Country (2023-2028) & (K Litre)

Table 80. Americas Human Recombinant Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Human Recombinant Insulin Sales Forecast by Region (2023-2028) & (K Litre)

Table 82. APAC Human Recombinant Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Human Recombinant Insulin Sales Forecast by Country (2023-2028) & (K Litre)

Table 84. Europe Human Recombinant Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Human Recombinant Insulin Sales Forecast by Country (2023-2028) & (K Litre)

Table 86. Middle East & Africa Human Recombinant Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Human Recombinant Insulin Sales Forecast by Type (2023-2028) & (K Litre)

Table 88. Global Human Recombinant Insulin Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Human Recombinant Insulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Human Recombinant Insulin Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Human Recombinant Insulin Sales Forecast by Application (2023-2028) & (K Litre)

Table 92. Global Human Recombinant Insulin Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Human Recombinant Insulin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Human Recombinant Insulin Revenue Market Share Forecast by Application (2023-2028)

Table 95. Novo Nordisk Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 96. Novo Nordisk Human Recombinant Insulin Product Offered

Table 97. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 98. Novo Nordisk Main Business

Table 99. Novo Nordisk Latest Developments

Table 100. Eli Lilly and Company Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 101. Eli Lilly and Company Human Recombinant Insulin Product Offered

Table 102. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 103. Eli Lilly and Company Main Business

Table 104. Eli Lilly and Company Latest Developments

Table 105. Sanofi Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 106. Sanofi Human Recombinant Insulin Product Offered

Table 107. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 108. Sanofi Main Business

Table 109. Sanofi Latest Developments

Table 110. Julphar Gulf Pharmaceutical Industries Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 111. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product Offered

Table 112. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 113. Julphar Gulf Pharmaceutical Industries Main Business

Table 114. Julphar Gulf Pharmaceutical Industries Latest Developments

Table 115. Bioton Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 116. Bioton Human Recombinant Insulin Product Offered

Table 117. Bioton Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 118. Bioton Main Business

Table 119. Bioton Latest Developments

Table 120. Gan & Lee Pharmaceuticals Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 121. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product Offered

Table 122. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 123. Gan & Lee Pharmaceuticals Main Business

Table 124. Gan & Lee Pharmaceuticals Latest Developments

Table 125. Zhuhai United Laboratories Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 126. Zhuhai United Laboratories Human Recombinant Insulin Product Offered

Table 127. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 128. Zhuhai United Laboratories Main Business

Table 129. Zhuhai United Laboratories Latest Developments

Table 130. Biocon Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 131. Biocon Human Recombinant Insulin Product Offered

Table 132. Biocon Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 133. Biocon Main Business

Table 134. Biocon Latest Developments

Table 135. Wanbang Biopharmaceuticals Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 136. Wanbang Biopharmaceuticals Human Recombinant Insulin Product Offered

Table 137. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 138. Wanbang Biopharmaceuticals Main Business

Table 139. Wanbang Biopharmaceuticals Latest Developments

Table 140. Dongbao Enterprise Group Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 141. Dongbao Enterprise Group Human Recombinant Insulin Product Offered

Table 142. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 143. Dongbao Enterprise Group Main Business

Table 144. Dongbao Enterprise Group Latest Developments

Table 145. PeproTech Basic Information, Human Recombinant Insulin Manufacturing Base, Sales Area and Its Competitors

Table 146. PeproTech Human Recombinant Insulin Product Offered

Table 147. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue ($ Million), Price (USD/Litre) and Gross Margin (2020-2022)

Table 148. PeproTech Main Business

Table 149. PeproTech Latest Developments

List of Figures

Figure 1. Picture of Human Recombinant Insulin

Figure 2. Human Recombinant Insulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Recombinant Insulin Sales Growth Rate 2017-2028 (K Litre)

Figure 7. Global Human Recombinant Insulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Recombinant Insulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rapid-Acting Human Insulin

Figure 10. Product Picture of Regular (Short Acting) Insulin

Figure 11. Product Picture of NPH (Intermediate Acting) Insulin

Figure 12. Product Picture of Long-Acting Human Insulin

Figure 13. Product Picture of Premixed Human Insulins Insulin

Figure 14. Global Human Recombinant Insulin Sales Market Share by Type in 2021

Figure 15. Global Human Recombinant Insulin Revenue Market Share by Type (2017-2022)

Figure 16. Human Recombinant Insulin Consumed in Hospital

Figure 17. Global Human Recombinant Insulin Market: Hospital (2017-2022) & (K Litre)

Figure 18. Human Recombinant Insulin Consumed in Retail Pharmacy

Figure 19. Global Human Recombinant Insulin Market: Retail Pharmacy (2017-2022) & (K Litre)

Figure 20. Human Recombinant Insulin Consumed in Online Pharmacies

Figure 21. Global Human Recombinant Insulin Market: Online Pharmacies (2017-2022) & (K Litre)

Figure 22. Human Recombinant Insulin Consumed in Other

Figure 23. Global Human Recombinant Insulin Market: Other (2017-2022) & (K Litre)

Figure 24. Global Human Recombinant Insulin Sales Market Share by Application (2017-2022)

Figure 25. Global Human Recombinant Insulin Revenue Market Share by Application in 2021

Figure 26. Human Recombinant Insulin Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Human Recombinant Insulin Revenue Market Share by Company in 2021

Figure 28. Global Human Recombinant Insulin Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Human Recombinant Insulin Revenue Market Share by Geographic Region in 2021

Figure 30. Global Human Recombinant Insulin Sales Market Share by Region (2017-2022)

Figure 31. Global Human Recombinant Insulin Revenue Market Share by Country/Region in 2021

Figure 32. Americas Human Recombinant Insulin Sales 2017-2022 (K Litre)

Figure 33. Americas Human Recombinant Insulin Revenue 2017-2022 ($ Millions)

Figure 34. APAC Human Recombinant Insulin Sales 2017-2022 (K Litre)

Figure 35. APAC Human Recombinant Insulin Revenue 2017-2022 ($ Millions)

Figure 36. Europe Human Recombinant Insulin Sales 2017-2022 (K Litre)

Figure 37. Europe Human Recombinant Insulin Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Human Recombinant Insulin Sales 2017-2022 (K Litre)

Figure 39. Middle East & Africa Human Recombinant Insulin Revenue 2017-2022 ($ Millions)

Figure 40. Americas Human Recombinant Insulin Sales Market Share by Country in 2021

Figure 41. Americas Human Recombinant Insulin Revenue Market Share by Country in 2021

Figure 42. United States Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Human Recombinant Insulin Sales Market Share by Region in 2021

Figure 47. APAC Human Recombinant Insulin Revenue Market Share by Regions in 2021

Figure 48. China Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Human Recombinant Insulin Sales Market Share by Country in 2021

Figure 55. Europe Human Recombinant Insulin Revenue Market Share by Country in 2021

Figure 56. Germany Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Human Recombinant Insulin Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Human Recombinant Insulin Revenue Market Share by Country in 2021

Figure 63. Egypt Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Human Recombinant Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Human Recombinant Insulin in 2021

Figure 69. Manufacturing Process Analysis of Human Recombinant Insulin

Figure 70. Industry Chain Structure of Human Recombinant Insulin

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles